Marks MJ - Search Results

1

Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.

Marks MJ, O'Neill HC, Wynalda-Camozzi KM, Ortiz NC, Simmons EE, Short CA, Butt CM, McIntosh JM, Grady SR. Marks MJ, et al. Neuropharmacology. 2015 Dec;99:142-55. doi: 10.1016/j.neuropharm.2015.07.019. Epub 2015 Jul 17. Neuropharmacology. 2015. PMID: 26192545 Free PMC article.

2

Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.

Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC. Marks MJ, et al. Neuropharmacology. 2004 Jun;46(8):1141-57. doi: 10.1016/j.neuropharm.2004.02.009. Neuropharmacology. 2004. PMID: 15111021

3

The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.

Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ. Salminen O, et al. Among authors: marks mj. Neuropharmacology. 2005 Apr;48(5):696-705. doi: 10.1016/j.neuropharm.2004.12.011. Neuropharmacology. 2005. PMID: 15814104

4

Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors.

Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ. Grady SR, et al. Among authors: marks mj. Neuropharmacology. 2010 Jun;58(7):1054-66. doi: 10.1016/j.neuropharm.2010.01.013. Epub 2010 Jan 28. Neuropharmacology. 2010. PMID: 20114055 Free PMC article.

5

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release.

Grady SR, Wageman CR, Patzlaff NE, Marks MJ. Grady SR, et al. Among authors: marks mj. Neuropharmacology. 2012 Apr;62(5-6):1935-43. doi: 10.1016/j.neuropharm.2011.12.026. Epub 2012 Jan 2. Neuropharmacology. 2012. PMID: 22239849 Free PMC article.

6

Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.

Ortiz NC, O'Neill HC, Marks MJ, Grady SR. Ortiz NC, et al. Among authors: marks mj. Nicotine Tob Res. 2012 Jun;14(6):711-9. doi: 10.1093/ntr/ntr284. Epub 2012 Jan 12. Nicotine Tob Res. 2012. PMID: 22241831 Free PMC article.

7

Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures.

Zambrano CA, Salamander RM, Collins AC, Grady SR, Marks MJ. Zambrano CA, et al. Among authors: marks mj. J Pharmacol Exp Ther. 2012 Aug;342(2):245-54. doi: 10.1124/jpet.112.192542. Epub 2012 Apr 24. J Pharmacol Exp Ther. 2012. PMID: 22532626 Free PMC article.

8

α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.

Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, Whiteaker P. Marks MJ, et al. J Neurochem. 2014 Jul;130(2):185-98. doi: 10.1111/jnc.12721. Epub 2014 Apr 19. J Neurochem. 2014. PMID: 24661093 Free PMC article.

9

Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure.

Zambrano CA, Short CA, Salamander RM, Grady SR, Marks MJ. Zambrano CA, et al. Among authors: marks mj. Pharmacol Res Perspect. 2015 Mar;3(2):e00111. doi: 10.1002/prp2.111. Pharmacol Res Perspect. 2015. PMID: 25729578 Free PMC article.

10

[No title available]

[No authors listed] [No authors listed] PMID: 32585787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters